Sign In
Buy BHC
$4.95
-0.0600 (-1.20%)
At Close: Jun 03, 2026
Next generation product may increase gastrointestinal luminal concentration while limiting system exposure LAVAL, QC / ACCESSWIRE / November 18, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC)
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its exclusive
Are Medical Stocks Lagging Bausch Health (BHC) This Year?
10:40am, Wednesday, 06'th Nov 2024
Here is how Bausch Health (BHC) and Butterfly Network, Inc. (BFLY) have performed compared to their sector so far this year.
Why Bausch Health (BHC) is a Top Momentum Stock for the Long-Term
10:55am, Monday, 04'th Nov 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Bausch Health Q3 Earnings and Revenues Top, Xifaxan Boosts Sales
02:45pm, Friday, 01'st Nov 2024
BHC's third-quarter adjusted earnings and revenues beat estimates. The increase in revenue guidance is positive.
Compared to Estimates, Bausch (BHC) Q3 Earnings: A Look at Key Metrics
10:00pm, Wednesday, 30'th Oct 2024
While the top- and bottom-line numbers for Bausch (BHC) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare
Bausch Health (BHC) Beats Q3 Earnings and Revenue Estimates
09:25pm, Wednesday, 30'th Oct 2024
Bausch Health (BHC) came out with quarterly earnings of $1.12 per share, beating the Zacks Consensus Estimate of $1.03 per share. This compares to earnings of $1.03 per share a year ago.
Bausch Health Companies, Inc. (BHC) Q3 2024 Earnings Call Transcript
09:17pm, Wednesday, 30'th Oct 2024
Bausch Health Companies, Inc. (NYSE:BHC ) Q3 2024 Earnings Conference Call October 30, 2024 5:00 PM ET Company Participants Garen Sarafian - IR Thomas Appio - CEO Jean-Jacques Charhon - EVP & CFO Conf
Bausch + Lomb Announces Third-Quarter 2024 Results
07:00am, Wednesday, 30'th Oct 2024
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its third-quar
Additional ACG presentation to focus on impact of Xifaxan on OHE rehospitalizations LAVAL, QC / ACCESSWIRE / October 27, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterolog
Bausch Health (BHC) Reports Next Week: What to Expect
11:06am, Wednesday, 23'rd Oct 2024
Bausch (BHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bausch + Lomb Sale Process Gains Momentum As TPG And Blackstone Join Forces
10:04am, Monday, 14'th Oct 2024
Private equity firms TPG and Blackstone are joining forces in a bid to acquire eye care company Bausch + Lomb BLCO, the Financial Times reported.
Bausch + Lomb Receives FDA Approval for enVista® Envy™ Full Range of Vision Intraocular Lens
07:00am, Monday, 14'th Oct 2024
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the U.S.
Bausch Health to Announce Third Quarter 2024 Results on October 30, 2024
04:05pm, Wednesday, 09'th Oct 2024
LAVAL, QC / ACCESSWIRE / October 9, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release third quarter 2024 financial results after market close on Wednesday, October 30, 2024. Bausch
Findings show care for chronic liver disease patients is falling on non-specialists who need stronger education and support to ensure patients receive timely, optimal care1 LAVAL, QC / ACCESSWIRE / Oc
